Primary |
Metastatic Renal Cell Carcinoma |
20.9% |
Hepatitis C |
19.1% |
Chronic Hepatitis C |
12.9% |
Malignant Melanoma |
9.4% |
Product Used For Unknown Indication |
7.3% |
Renal Cell Carcinoma |
5.4% |
Drug Use For Unknown Indication |
4.1% |
Metastatic Malignant Melanoma |
3.3% |
Prophylaxis |
3.2% |
Multiple Myeloma |
3.0% |
Hypertension |
2.5% |
Gout |
1.9% |
Hypertonia |
1.4% |
Multiple Sclerosis |
1.0% |
Bone Pain |
0.8% |
Diabetes Mellitus |
0.8% |
Renal Cancer Metastatic |
0.8% |
Teratoma |
0.8% |
Non-hodgkin's Lymphoma |
0.6% |
Pain |
0.6% |
|
Hepatitis C |
16.9% |
Disease Progression |
10.1% |
Hepatic Neoplasm Malignant |
8.4% |
Weight Decreased |
7.3% |
Pulmonary Embolism |
6.7% |
Viral Load Increased |
5.1% |
Vomiting |
5.1% |
Depression |
4.5% |
Nausea |
3.9% |
Pyrexia |
3.9% |
Malignant Melanoma |
3.4% |
Malignant Neoplasm Progression |
3.4% |
Death |
2.8% |
Portal Vein Thrombosis |
2.8% |
Renal Failure Acute |
2.8% |
Thrombocytopenia |
2.8% |
Upper Gastrointestinal Haemorrhage |
2.8% |
White Blood Cell Count Decreased |
2.8% |
Gliosis |
2.2% |
Hyponatraemia |
2.2% |
|
Secondary |
Metastatic Renal Cell Carcinoma |
22.3% |
Hepatitis C |
20.0% |
B-cell Lymphoma |
16.2% |
Drug Use For Unknown Indication |
9.5% |
Renal Cell Carcinoma |
7.4% |
Chronic Hepatitis C |
4.6% |
Product Used For Unknown Indication |
3.5% |
Renal Cancer |
2.5% |
Hypertension |
1.9% |
Malignant Melanoma |
1.6% |
Chronic Myeloid Leukaemia |
1.5% |
Hiv Infection |
1.5% |
Prophylaxis |
1.2% |
Gout |
1.1% |
Multiple Myeloma |
1.1% |
Hepatitis |
0.9% |
Metastases To Central Nervous System |
0.9% |
Non-hodgkin's Lymphoma Stage Iii |
0.9% |
Renal Cancer Metastatic |
0.9% |
Cardiac Failure |
0.7% |
|
Hepatic Neoplasm Malignant |
10.9% |
Vomiting |
8.8% |
Thrombocytopenia |
8.2% |
Rash |
6.1% |
Anaemia |
5.4% |
Hip Fracture |
5.4% |
Inappropriate Antidiuretic Hormone Secretion |
5.4% |
Pyrexia |
5.4% |
Upper Gastrointestinal Haemorrhage |
5.4% |
Disease Progression |
4.8% |
Nausea |
4.8% |
Pulmonary Embolism |
4.1% |
Prostate Cancer |
3.4% |
Pruritus |
3.4% |
Retinopathy |
3.4% |
Weight Decreased |
3.4% |
White Blood Cell Count Decreased |
3.4% |
Acute Myeloid Leukaemia |
2.7% |
Epilepsy |
2.7% |
Stomatitis |
2.7% |
|
Concomitant |
Hepatitis C |
22.3% |
Drug Use For Unknown Indication |
18.5% |
Lung Neoplasm Malignant |
7.6% |
Chronic Hepatitis C |
7.0% |
Eczema |
5.7% |
Hepatic Cirrhosis |
5.1% |
Hiv Infection |
5.1% |
Pain |
4.5% |
Product Used For Unknown Indication |
3.2% |
Schizophrenia |
3.2% |
Colitis |
2.5% |
Immunosuppression |
2.5% |
Metastases To Lung |
2.5% |
Behcet's Syndrome |
1.9% |
Liver Disorder |
1.9% |
Epididymitis |
1.3% |
Hypertension |
1.3% |
Insomnia |
1.3% |
Liver Transplant |
1.3% |
Renal Cancer Metastatic |
1.3% |
|
Weight Increased |
28.6% |
White Blood Cell Count Decreased |
16.7% |
Blindness |
7.1% |
Drug Rash With Eosinophilia And Systemic Symptoms |
4.8% |
Keratitis Bacterial |
4.8% |
Weight Decreased |
4.8% |
Adverse Event |
2.4% |
Anaemia |
2.4% |
Arthritis |
2.4% |
Death |
2.4% |
Disease Progression |
2.4% |
Dyspnoea |
2.4% |
Erythema |
2.4% |
Fatigue |
2.4% |
Headache |
2.4% |
Hepatic Cirrhosis |
2.4% |
Metastases To Central Nervous System |
2.4% |
Oedema Peripheral |
2.4% |
Orbital Oedema |
2.4% |
Osteonecrosis Of Jaw |
2.4% |
|